|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0299 | ED149375 | General Research Use | No | Male | White | 64 | 4 - AREDS AMD Severity Scale Step 3 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0356 | ED148455 | General Research Use | No | Female | White | 76 | 4 - AREDS AMD Severity Scale Step 3 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_0561 | ED148304 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 1 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1025 | ED148764 | General Research Use | No | Female | White | 68 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1406 | ED148294 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1670 | ED148229 | General Research Use | No | Female | Asian | 72 | 4 - AREDS AMD Severity Scale Step 4 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1964 | ED148467 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 2 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_2071 | ED148780 | General Research Use | No | Female | White | 50 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_2374 | ED148287 | General Research Use | No | Female | White | 80 | 4 - AREDS AMD Severity Scale Step 4 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2409 | ED149700 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_3387 | ED149521 | General Research Use | No | Male | White | 75 | 4 - AREDS AMD Severity Scale Step 2 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_3702 | ED149283 | Eye Disease Only | No | Female | White | 66 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_4033 | ED149184 | General Research Use | No | Female | White | 74 | 4 - AREDS AMD Severity Scale Step 1 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_4105 | ED149265 | General Research Use | No | Male | Black or African American | 68 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0115 | ED148309 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0224 | ED148870 | General Research Use | No | Male | White | 72 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0678 | ED148084 | General Research Use | No | Female | White | 80 | 4 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0698 | ED148658 | General Research Use | No | Male | White | 69 | 4 - AREDS AMD Severity Scale Step 2 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0948 | ED148457 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 1 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1013 | ED149348 | General Research Use | No | Male | White | 69 | 4 - AREDS AMD Severity Scale Step 2 | 5 - AREDS AMD Severity Scale Step 5 |